"RHYTHM HEART INSTITUTE- Vadodara's best Multi specialty's Hospital."

During the past decade, Rhythm Heart Institute conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rhythm Heart Institute" #1 sponsor was "Vicore Pharma AB" with 3 trials, followed by "Pfizer" with 2 trials sponsored, "Dr. Reddy's Laboratories Limited" with 1 trials sponsored, "Kowa Research Institute, Inc." with 1 trials sponsored and "Novartis Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rhythm Heart Institute" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "CRO: JSS Medical Research India Pvt. Ltd." with 1 trials as a collaborator, "Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation" with 1 trials as a collaborator, "Molecular Partners AG" with 1 trials as a collaborator and "Orphan Reach" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Rhythm Heart Institute" are "COVID-19" (3 trials), "Cardiovascular Disease" (2 trials), "Covid19" (2 trials), "Atrial Fibrillation" (1 trials) and "COVID-19 Prevention" (1 trials). Many other conditions were trialed in "Rhythm Heart Institute" in a lesser frequency.

Most popular intervention types in "Rhythm Heart Institute" are "Drug" (8 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "C21" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Edoxaban" (1 trials) and "Gam-COVID-Vac" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rhythm Heart Institute" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Rhythm Heart Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Rhythm Heart Institute, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Rhythm Heart Institute, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".